Your session is about to expire
← Back to Search
Methylprednisolone taper for Total Knee Replacement
Study Summary
This trial will evaluate whether or not a methylprednisolone taper can improve range of motion or delayed recovery in patients six weeks to three months post-TKA.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What medical conditions typically necessitate Methylprednisolone tapering?
"For ophthalmia, sympathetic the most efficacious treatment tends to be a Methylprednisolone taper. This same medication is also beneficial for managing scalp structure, temporal arteritis and lupus erythematosus."
Are there vacancies in this research trial for participants?
"Affirmative. The clinical trial registry on clincialtrials.gov indicates that this study is recruiting participants and was first announced on March 3rd 2022, with the most recent update made April 26th of this year. 112 individuals are required to be recruited from one site."
Could you provide insight into the potential hazards associated with a Methylprednisolone taper regimen?
"There is a body of evidence in favour of Methylprednisolone taper, so it has been allocated a score of 3."
How many individuals are currently enrolled in this research endeavor?
"Affirmative. According to records available on clinicaltrials.gov, this medical experiment was initially posted on March 3rd 2022 and is currently recruiting participants. This initiative requires 112 patients from a single site to be enrolled."
Has research been conducted to explore the efficacy of a Methylprednisolone taper?
"At this time, there are 150 studies on Methylprednisolone taper. Of these trials, 39 have reached Phase 3. While the majority of research is based in Houston, Texas; 6845 sites worldwide are participating in related clinical investigations."
Share this study with friends
Copy Link
Messenger